306 Participants Needed

Kick-Nic! App for Quitting Vaping

TL
Overseen ByThomas Liss
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

High school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they will be given access to use the Kick-Nic! app or referred to the NCI Quit Vaping website. This will be followed by 1, 2, 3, and 6 month follow up visits. Qualitative interviews with participants and school staff will also be conducted to obtain feedback on the app and best ways to implement/disseminate the app. Abstinence rates will be assessed biweekly during treatment including at end of treatment (EOT), and then at 1, 2, 3 and 6 month follow ups (FU). Biochemical verification (salivary cotinine \< 30 ng.ml) of self-reports of abstinence will be conducted at EOT and 6-month FU.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you have been using anxiolytics, antidepressants, or other psychostimulants for less than 2 months, you may not be eligible to participate.

What data supports the effectiveness of the treatment Kick-Nic! for quitting vaping?

Research shows that smartphone apps can help people quit smoking by providing support and improving adherence to nicotine replacement therapy (NRT). Since vaping involves nicotine, similar app-based interventions may also help people quit vaping by offering real-time support and tracking usage.12345

How is the Kick-Nic! treatment for quitting vaping different from other treatments?

Kick-Nic! is unique because it is an app designed specifically for quitting vaping, whereas most existing apps and treatments focus on smoking cessation. This app likely uses interactive and personalized features to engage users, similar to other smoking cessation apps, but tailored for vaping.678910

Research Team

SK

Suchitra Krishnan-Sarin, Ph.D.

Principal Investigator

Yale University School of Medicine, Dept of Psychiatry

Eligibility Criteria

This trial is for high school students who are currently vaping and want to quit. They must be willing to participate in an 8-week program and attend follow-up visits up to 6 months after the treatment period. The study excludes individuals who do not meet these criteria.

Inclusion Criteria

I am between 13 and 19 years old.
Want to quit using e-cigarettes
Regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week
See 1 more

Exclusion Criteria

I have been on stable doses of mental health medications for over 2 months.
I do not have a history of severe mental health issues that could increase my risk.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Kick-Nic! app or are referred to the NCI Quit Vaping website for an 8-week period

8 weeks
4 biweekly assessments (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment with follow-up visits at 1, 2, 3, and 6 months

6 months
4 visits (in-person or virtual)

Treatment Details

Interventions

  • Kick-Nic!
Trial Overview The Kick-Nic! Youth Quit Vaping App trial tests if a mobile app can help teens stop vaping compared to using a control website by NCI. Participants will randomly receive either the app or website access, with their progress monitored through regular check-ins and interviews.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ACTIVEExperimental Treatment1 Intervention
Participants in the active group will be given access to the Kick-Nic! app to use for vaping cessation.
Group II: CONTROLActive Control1 Intervention
Participants in the control group will be referred to the NCI Quit Vaping website.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

A pilot study involving 35 pregnant women showed that the 'NicUse' smartphone app for monitoring nicotine replacement therapy (NRT) adherence was highly acceptable, with 96% of users finding it easy to use and clear in its instructions.
The data collected through NicUse demonstrated strong validity, as there was a very high correlation (r = 0.95) between the number of cigarettes reported in the app and exhaled carbon monoxide readings, indicating reliable self-reporting of smoking behavior.
The development and acceptability testing of an app-based smart survey system to record smoking behaviour, use of nicotine replacement therapy (NRT) and e-cigarettes.Huang, Y., Emery, J., Naughton, F., et al.[2022]
The NRT2Quit smartphone app showed preliminary evidence of improving short-term smoking cessation rates and adherence to nicotine replacement therapy (NRT), with a biochemically verified quit rate of 25% in the intervention group compared to 8% in the control group, although the results were not statistically significant due to low participant numbers.
Participants using the NRT2Quit app logged in more frequently and were more likely to use NRT at follow-up (100% vs. 28.6%), suggesting that the app may enhance engagement and support for smokers trying to quit.
Pragmatic randomised trial of a smartphone app (NRT2Quit) to improve effectiveness of nicotine replacement therapy in a quit attempt by improving medication adherence: results of a prematurely terminated study.Herbec, A., Brown, J., Shahab, L., et al.[2023]
Among 311,567 users of the iCoach app for smoking cessation, 26,785 steady users were identified, with more intensive app use linked to higher rates of smoking cessation, improved quitting stages, and increased self-efficacy over time.
The most significant improvements in smoking-related outcomes were observed within the first 3 months of app use, particularly among older users and women, who were more likely to engage with the app intensively.
Use of the Smoking Cessation App Ex-Smokers iCoach and Associations With Smoking-Related Outcomes Over Time in a Large Sample of European Smokers: Retrospective Observational Study.Mansour, MB., Busschers, WB., Crone, MR., et al.[2023]

References

The development and acceptability testing of an app-based smart survey system to record smoking behaviour, use of nicotine replacement therapy (NRT) and e-cigarettes. [2022]
Pragmatic randomised trial of a smartphone app (NRT2Quit) to improve effectiveness of nicotine replacement therapy in a quit attempt by improving medication adherence: results of a prematurely terminated study. [2023]
Use of the Smoking Cessation App Ex-Smokers iCoach and Associations With Smoking-Related Outcomes Over Time in a Large Sample of European Smokers: Retrospective Observational Study. [2023]
The Stop-Tabac smartphone application for smoking cessation: study protocol for a randomized controlled trial in the general population. [2021]
Tobacco cessation mobile app intervention (Just Kwit! study): protocol for a pilot randomized controlled pragmatic trial. [2020]
Cigbreak Free: Game to Quit Smoking. [2019]
A content analysis of popular smartphone apps for smoking cessation. [2022]
Smoking Cessation: Services and Applications for Mobile Devices. [2018]
Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation. [2022]
NHS quit smoking. [2016]